Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage?
- 15 June 2017
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 22 (5) , 945-953
Abstract
Objective To assess the impact of body mass index (BMI) on radiotherapy toxicities in endometrial cancer patients. Methods This was a retrospective cohort study of women diagnosed with endometrial cancer between January 2006 and December 2014 at the Royal Cornwall Hospital Trust. Women who received radiotherapy as part of their treatment, including external beam radiotherapy (EBRT) and/or vaginal brachytherapy were included. Radiation-related toxicities were graded according to the Radiation Therapy Oncology Group (RTOG) guidelines. Toxicity outcomes were compared across BMI groups—non-obese (BMI 2) and obese (BMI ≥30 kg/m2)—according to radiotherapy treatment received (EBRT, brachytherapy or a combination). Results Of a total of 159 women who received radiotherapy, 110 were eligible for inclusion in the study. Sixty-three women had a BMI 2 and 47 women were obese. Obese women had poorer Eastern Cooperative Oncology Group performance status (P = 0.021) and more comorbidities (P < 0.001) compared to the non-obese group. Total (any) toxicity rates were 60.3, 72.7 and 52.0% for EBRT and brachytherapy (N = 63), single-mode EBRT (N = 22) and brachytherapy (N = 25), respectively. BMI was not associated with the incidence of acute and late radiation toxicities in the different radiotherapy groups, and there were no differences in individual complications between the BMI groups. Conclusion When comparing obese to non-obese women, obesity does not negatively impact the incidence of radiation toxicities in endometrial cancer. However, toxicities remain an important challenge as they are common and negatively influence the quality of life (QoL) of survivors. Future studies need to further explore the role of BMI and possible interventions to improve toxicities and QoL.Keywords
This publication has 27 references indexed in Scilit:
- Utilising pseudo-CT data for dose calculation and plan optimization in adaptive radiotherapyAustralasian Physics & Engineering Sciences in Medicine, 2015
- Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignanciesGynecologic Oncology, 2015
- Global burden of cancer attributable to high body-mass index in 2012: a population-based studyThe Lancet Oncology, 2015
- The impact of BMI on quality of life in obese endometrial cancer survivors: Does size matter?Gynecologic Oncology, 2014
- Role of image guided radiation therapy in obese patients with gynecologic malignanciesPractical Radiation Oncology, 2013
- External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial CarcinomaInternational Journal of Gynecological Cancer, 2012
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trialThe Lancet, 2010
- Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysisThe Lancet, 2009
- Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinomaCancer, 2006
- Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignanciesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002